Gilder Gagnon Howe & CO LLC Renalytix PLC Transaction History

Gilder Gagnon Howe & CO LLC

  • $7.02 Billion
  • Q1 2025

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
N/A
-47,725 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
N/A
-403 Reduced 0.84%
47,725 $401,000
Q3 2021

Nov 15, 2021
SELL
N/A
-19,277 Reduced 28.6%
48,128 $470,000
Q2 2021

Aug 16, 2021
SELL
N/A
-113,251 Reduced 62.69%
67,405 $1.01 Million
Q1 2021

May 17, 2021
SELL
N/A
-23,771 Reduced 11.63%
180,656 $2.34 Million
Q4 2020

Feb 16, 2021
SELL
N/A
-24,365 Reduced 10.65%
204,427 $1.36 Million
Q3 2020

Nov 16, 2020
SELL
N/A
-17,790 Reduced 7.21%
228,792 $1.26 Million
Q2 2020

Aug 14, 2020
BUY
N/A
50,828 Added 25.97%
246,582 $1.62 Million
Q1 2020

May 15, 2020
BUY
N/A
76,117 Added 63.62%
195,754 $534,000
Q4 2019

Feb 14, 2020
BUY
N/A
119,637 New
119,637 $577,000

About Renalytix Plc

RENX.L Quotes by TradingView
  • Ticker RENX.L
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 74,891,800
  • Market Cap $51.6M
More about RENX.L
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email